Company receives acceptability, in principle, for ZyVac TCV making it eligible for purchase by United Nations procurement agencies
Product basket comprises 2,047 medicines and 300 surgical devices covering all major therapeutic groups
The proceeds from its fresh issuance to the extent of Rs 107 crore will be utilized for funding the capital expenditure requirements
Financing includes new funding from leading global organizations Eli Lilly and Company and EDBI
JB’s absolute Scope1 & Scope2 emissions reduced by 13.9 % in the last financial year, despite turnover increasing by 11%
Diltiazem Hydrochloride Extended-Release Capsules USP are indicated for the treatment of hypertension
Spread over 1.26 lakh sq ft building, the super-specialty eye hospital will perform 30,000 free eye surgeries annually for economically weaker sections
Fludrocortisone acetate tablets will be produced at the Group's manufacturing site at Moraiya, Ahmedabad
Subscribe To Our Newsletter & Stay Updated
